The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer's disease
- PMID: 28704199
- DOI: 10.1515/revneuro-2017-0013
The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer's disease
Abstract
Alzheimer's disease (AD) is the most common neurodegenerative disorder leading to dementia in the elderly population. AD is associated with the buildup of β-amyloid and tau, which aggregate into extracellular plaques and neurofibrillary tangles. Although the exact mechanism of pathological process of AD is unclear, the dysfunction of protein degradation mechanisms has been proposed to play an important role in AD. The cellular degradation of abnormal or misfolded proteins consists of three different mechanisms: the ubiquitin proteasomal system (UPS), autophagy-lysosomal pathway (ALP), and interaction of molecular chaperones with UPS or ALP. Any disturbance to these systems causes proteins to accumulate, resulting in pathological process of AD. In this review, we summarize the knowledge of protein degradation pathways in the pathogenesis of AD in light of the current literature. In the future, the regulation UPS or ALP machineries could be the cornerstones of the treatment of AD.
Keywords: Alzheimer disease; autophagy-lysosomal pathway; tau; ubiquitin proteasomal system; β-amyloid.
Similar articles
-
The Ubiquitin System in Alzheimer's Disease.Adv Exp Med Biol. 2020;1233:195-221. doi: 10.1007/978-3-030-38266-7_8. Adv Exp Med Biol. 2020. PMID: 32274758 Review.
-
Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system.Prog Neurobiol. 2013 Jun;105:49-59. doi: 10.1016/j.pneurobio.2013.03.001. Epub 2013 Mar 23. Prog Neurobiol. 2013. PMID: 23528736 Review.
-
Alzheimer's disease and the autophagic-lysosomal system.Neurosci Lett. 2019 Apr 1;697:49-58. doi: 10.1016/j.neulet.2018.05.017. Epub 2018 May 18. Neurosci Lett. 2019. PMID: 29758300 Review.
-
Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis.Neurosci Lett. 2019 Jun 11;703:68-78. doi: 10.1016/j.neulet.2019.03.016. Epub 2019 Mar 16. Neurosci Lett. 2019. PMID: 30890471 Free PMC article. Review.
-
Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.Neurol Res. 2014 Mar;36(3):276-82. doi: 10.1179/1743132813Y.0000000288. Neurol Res. 2014. PMID: 24512022 Review.
Cited by
-
Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites.J Alzheimers Dis. 2022;86(4):1875-1895. doi: 10.3233/JAD-215448. J Alzheimers Dis. 2022. PMID: 35253754 Free PMC article.
-
Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease.Front Aging Neurosci. 2022 Sep 7;14:977411. doi: 10.3389/fnagi.2022.977411. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36158539 Free PMC article. Review.
-
Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease.Exp Mol Med. 2019 Nov 15;51(11):1-17. doi: 10.1038/s12276-019-0326-z. Exp Mol Med. 2019. PMID: 31727875 Free PMC article.
-
Lipocalin-2: a therapeutic target to overcome neurodegenerative diseases by regulating reactive astrogliosis.Exp Mol Med. 2023 Oct;55(10):2138-2146. doi: 10.1038/s12276-023-01098-7. Epub 2023 Oct 2. Exp Mol Med. 2023. PMID: 37779143 Free PMC article. Review.
-
Emerging Role of Sorting Nexin 17 in Human Health and Disease.Curr Protein Pept Sci. 2024;25(10):814-825. doi: 10.2174/0113892037284582240522155112. Curr Protein Pept Sci. 2024. PMID: 38874037 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical